home / stock / azn / azn articles

AZN Articles, AstraZeneca PLC - From 03/18/24

Stock Information
Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com
Menu
AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...
AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer | Benzinga

Monday, AstraZeneca Plc (NASDAQ:PLC) released latest analysis of the results from the DUO-E Phase 3 trial of Imfinzi (durvaluma...
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus | Benzinga

Amid the ongoing scrutiny from Congress, WuXi AppTec and its affiliates face another setback as the Biotechnology Innovation Organization...

AstraZeneca Beefs Up Its Endocrine Disease Pipeline With Amolyt Pharma Deal Worth $1.05B | Benzinga

Thursday, AstraZeneca Plc (NASDAQ:AZN) agreed to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on ...

What's Going On With Silence Therapeutics Stock Today? | Benzinga

Silence Therapeutics Plc (NASDAQ:SLN) shares are trading lower in the morning session on Wednesday. The company reported a loss per share of (...
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 | Benzinga

In a move outlined in his upcoming State of the Union address, President Joe Biden is pushing for an increase in the number of prescripti...

Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic | Benzinga

As President Joe Biden prepares for his State of the Union address on Thursday, he's expected to touch on several key issues including Bidenom...

EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows | Benzinga

Wednesday, Vivani Medical Inc (NASDAQ:VANI) released preclinical data on weight loss effects for NPM-115, the company’s miniature, ...
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors | Benzinga

The race for new drugs to fight obesity and associated diabetes and cardiovascular diseases heated up on Monday after positive results from trials ...

Why AstraZeneca Stock Is Trading Higher Tuesday | Benzinga

Monday, the FDA approved AstraZeneca Plc's (NASDAQ:AZN) Tagrisso (osimertinib) plus chemotherapy for locally advanced or metast...

This Analyst Slightly Lowers AstraZeneca Forecast Amid Earnings Concerns, Although Still Bullish on Future Growth Potential | Benzinga

Thursday, AstraZeneca Plc (NASDAQ:AZN) reported fourth-quarter 2023 sales of $12.02 billion, up 7% Y/Y (+8% at constant currency), slight...
Previous 10 Next 10